591671
Apolizumab (HLA-DRB)

Größe
£749.00
- SKU:
- 591671
- Reinheit:
- ≥95%
- Lagerbedingungen:
- -20°C
- Hersteller:
- United States Biological
- Host:
- Human
- Immunogen:
- Recombinant protein corresponding to humanized HLA-DRB [Homo sapiens], expressed in CHO cells.
- Format:
- Supplied as a liquid in PBS, pH 7.5.
- Weitere Details:
- Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers. Apolizumab is a humanized monoclonal antibody directed against 1D10, a polymorphic determinant on the HLA-DR beta chain that is expressed on normal and neoplastic B cells. Apolizumab induces complement-mediated cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and apoptosis of 1D10 antigen-positive B cells in vitro. Applications: Suitable for use in ELISA and SDS-PAGE. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
- Versandbedingungen:
- Blue Ice
